Literature DB >> 14980268

Prophylaxis, therapy and prevention of viral respiratory infections.

Dimitris A Kafetzis1.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 14980268      PMCID： PMC7128272          DOI： 10.1016/s1526-0542(04)90035-8

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN： 1526-0542            Impact factor:   2.726


× No keyword cloud information.
  38 in total

1.  Burden of disease--implications for future research.

Authors:  C M Michaud; C J Murray; B R Bloom
Journal:  JAMA       Date:  2001-02-07       Impact factor: 56.272

2.  Effectiveness of palivizumab: evaluation of outcomes from the 1998 to 1999 respiratory syncytial virus season. The Palivizumab Outcomes Study Group.

Authors:  M Sorrentino; T Powers
Journal:  Pediatr Infect Dis J       Date:  2000-11       Impact factor: 2.129

3.  Rhinovirus as a lower respiratory tract pathogen in infants.

Authors:  H J Schmidt; R J Fink
Journal:  Pediatr Infect Dis J       Date:  1991-09       Impact factor: 2.129

4.  Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus.

Authors:  S Johnson; C Oliver; G A Prince; V G Hemming; D S Pfarr; S C Wang; M Dormitzer; J O'Grady; S Koenig; J K Tamura; R Woods; G Bansal; D Couchenour; E Tsao; W C Hall; J F Young
Journal:  J Infect Dis       Date:  1997-11       Impact factor: 5.226

Review 5.  Vitamin C intake and susceptibility to pneumonia.

Authors:  H Hemilä
Journal:  Pediatr Infect Dis J       Date:  1997-09       Impact factor: 2.129

6.  A randomized, controlled trial of vitamin A in children with severe measles.

Authors:  G D Hussey; M Klein
Journal:  N Engl J Med       Date:  1990-07-19       Impact factor: 91.245

7.  Reliability of the chest radiograph in the diagnosis of lower respiratory infections in young children.

Authors:  H D Davies; E E Wang; D Manson; P Babyn; B Shuckett
Journal:  Pediatr Infect Dis J       Date:  1996-07       Impact factor: 2.129

8.  Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza.

Authors:  F G Hayden; J J Treanor; R F Betts; M Lobo; J D Esinhart; E K Hussey
Journal:  JAMA       Date:  1996 Jan 24-31       Impact factor: 56.272

9.  Acute respiratory tract infections of children in hospital: a viral and Mycoplasma pneumoniae profile.

Authors:  L C Jennings; K P Dawson; G D Abbott; J Allan
Journal:  N Z Med J       Date:  1985-07-24

10.  Respiratory syncytial virus infection in children with bronchopulmonary dysplasia.

Authors:  J R Groothuis; K M Gutierrez; B A Lauer
Journal:  Pediatrics       Date:  1988-08       Impact factor: 7.124
View more
  1 in total

1.  Enhanced clinical utility of the NucliSens EasyQ RSV A+B Assay for rapid detection of respiratory syncytial virus in clinical samples.

Authors:  C Moore; M Valappil; S Corden; D Westmoreland
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-03       Impact factor: 3.267
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.